Honeywell > 实例探究 > Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months

Well-Monitored: Diabetes Product Provider Deploys 100,000 Devices in 18 Months

Honeywell Logo
公司规模
Large Corporate
产品
  • Honeywell Two-Way Cellular-Connected Handheld Blood Glucose Meter
技术栈
  • Machine-to-Machine (M2M) Communication
  • Cellular Connectivity
实施规模
  • Enterprise-wide Deployment
影响指标
  • Revenue Growth
  • Customer Satisfaction
  • Digital Expertise
技术
  • 网络与连接 - 蜂窝
  • 分析与建模 - 机器学习
适用行业
  • 医疗保健和医院
用例
  • 远程病人监护
  • 机器状态监测
服务
  • 系统集成
关于客户
The customer is a global healthcare device manufacturer specializing in helping people manage chronic conditions, particularly diabetes. They produce devices that transmit glucose levels and other pertinent information in real time to a network of providers. The company has a significant presence in the healthcare market and aims to expand its product offerings and services. With a focus on innovation and customer satisfaction, the company is dedicated to improving the quality of life for individuals with chronic conditions through advanced medical devices.
挑战
The global healthcare device manufacturer faced the challenge of quickly filling thousands of pre-release orders for a newly approved glucose monitoring device. Additionally, they needed to prepare for the successful deployment of future healthcare devices by establishing a partnership with an experienced managed mobility services provider. The company was experiencing overwhelming success and needed to ensure that they could meet the high customer demand for their new diabetes monitoring device.
解决方案
To address the overwhelming success and high demand for their new diabetes monitoring device, the company engaged Honeywell to deploy a two-way, cellular-connected handheld blood glucose meter. This device falls into the growing category of machine-to-machine (M2M) products, which are networked devices that communicate without human intervention, often as part of remote monitoring. Honeywell, with its extensive experience in M2M, leveraged its wide-ranging product expertise to deploy 100,000 devices. This partnership allowed the healthcare device manufacturer to quickly and efficiently meet the pre-release and new orders for their glucose monitoring device.
运营影响
  • The company has established an almost immediate and significant foothold in the $250 billion diabetes-management market.
  • With the successful launch of its product, the company gains funds for anticipated new products and expansion of services.
  • It has established a relationship with a reliable managed mobility services provider that will help the company rapidly deploy new devices in the future.
数量效益
  • Deployed 100,000 devices in 18 months.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。